classes of drugs for cll: Please tell me if i'm... - CLL Support

CLL Support

23,088 members39,650 posts

classes of drugs for cll

5 Replies

Please tell me if i'm wrong or need more info. I listed these because they seem different enough from each other with how they work. I used one example of each-sure many others go with them

1.covalent BKI- ibrutinib

2. non covalent BKI- loxo-305

3. BCI-2- venetoclax

4. ROR1- circumuzamab

5. monoclonal anti- Gazyva

Read more about...
5 Replies
81ue profile image
81ue

I've been interested in anti ROR1 Cirmtuzumab as a possible next drug if venetoclax no longer worked. Pros - long half life of 21 days, low dose, targets only cancer due to the ROR1 is almost exclusively on cancer cells

cllsociety.org/2018/07/ash-...

cyclist123 profile image
cyclist123 in reply to 81ue

Interesting that Kipps talked about the growth of cancer cells as a remnant of an organism's own past. He certainly sounded excited about Cirmtuzumab ...hadn't known of this one before.

cllady01 profile image
cllady01Former Volunteer

Not sure what you are asking, but here is a recent rundown of the various families of non-hodgkins treatments that looks pretty complete, but I can't attest to that, so don't quote me : - )

ncbi.nlm.nih.gov/pmc/articl...

in reply to cllady01

i like yours better than mine-thanks

glkmel profile image
glkmel

I started on Ibrutinib in 2015 shorty after diagnosis. Was still working slowly IMO, but when my Dr said the New England Medal Journal had published a study adding Venclexta and results Back in May, I said of course. I started in September and 200 mg in ramp up was great. More energy. But at 400 mg kept waiting to feel good again but didn’t. Soo, went back to 200mg daily and is working for me. I am also on allopurinol to protect kidneys as Venclexta pushed uratic acid up above normal. One week and it’s back in normal range. I will say my sodium has been running just under normal range and we cut back water from 100oz to about 70 oz daily. Sodium stays the same. So for now am enjoying what I have and will stay positive and as always, don’t worry but deal with whatever changes when it comes up. Enjoy the holiday season with friends and family.

Not what you're looking for?

You may also like...

Advances in Targeted Therapy for R/R CLL OncLive videos & transcripts by Nirav Shah MD & Nicole Lamanna MD

Advances in Targeted Therapy for R/R CLL (These OncLive presentations are intended for medical...

Classes of novel drugs

Since i have both p53 and p17 . Novel drugs are all i will have since chemo not effective and i...

Now showing on Vjhemonc CLL channel, Epcoritamab for Richter's, identifying high risk CLL, Pirtobrutinib Genomic Evolution, HOVON 141/VISION

The latest videos on the CLL channel...

BRUIN Study: phase 1/2 study of Pirtobrutinib (formerly Loxo 305) in relapsed or refractory B-cell malignancies

Patients discontinue BTKi's due to resistance and intolerance. We evaluated the safety and efficacy...

BTK Degrader Shows Potential for Treating Refractory CLL and SLL

A novel Bruton's tyrosine kinase (BTK) degrader, NX-2127, has shown potential for treating patients...